Biocause Pharma(000627)
Search documents
天茂集团(000627) - 2025-016-关于回购股份注销完成暨股份变动公告
2025-05-15 12:03
证券代码:000627 证券简称:天茂集团 公告编号:2025-016 天茂实业集团股份有限公司 关于回购股份注销完成暨股份变动的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性 陈述或者重大遗漏。 特别提示: 1、天茂实业集团股份有限公司(以下简称"公司")本次注销的股份数量为36,490,000 股,占公司本次注销前总股本的0.7386%。本次回购股份注销完成后,公司总股本由 4,940,629,165股变更为4,904,139,165股。 二、回购股份的注销情况 公司已于2025年5月15日在中国证券登记结算有限责任公司深圳分公司(以下简称"结算 公司")办理完毕上述回购股份的注销手续,本次注销的股份数量为36,490,000股,占公司本 次注销前总股本的比例为0.7386%。本次回购股份注销数量、完成日期、注销期限符合回购股 份注销相关法律法规的规定。 2、公司已于2025年5月15日在中国证券登记结算有限责任公司深圳分公司办理完毕上述回 购股份的注销手续。 根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第 9 号 ——回购股份》等相关规定,现 ...
刘益谦旗下天茂集团爆雷:保险主业不振,地产腾挪成谜
Tai Mei Ti A P P· 2025-05-09 11:02
Core Viewpoint - Tianmao Group is facing significant financial difficulties, including a continuous decline in stock prices and potential delisting risks due to substantial losses and regulatory scrutiny [1][2]. Financial Performance - Tianmao Group has reported a cumulative loss exceeding 1.1 billion yuan over the past two years, primarily due to the poor performance of its subsidiary, Guohua Life Insurance [1][2]. - For 2024, the company anticipates a net loss between 500 million to 750 million yuan, with total revenue projected to be between 40 billion to 43 billion yuan [2]. - Guohua Life Insurance has been a major contributor to these losses, with a net loss of 1.155 billion yuan in 2023 and 716 million yuan in the first half of 2024 [2]. Regulatory Issues - The company has received a notice from the China Securities Regulatory Commission regarding an investigation, which has led to a suspension of its stock trading [1]. - If the company fails to disclose its annual report within two months of the trading suspension, it may face delisting risks [1]. Investment and Business Strategy - Guohua Life Insurance has been heavily involved in real estate investments, which have drawn criticism and raised concerns about potential conflicts of interest and fund misappropriation [1][7]. - The company has seen a significant increase in investment properties, rising by 73.96% from 11.2 billion yuan in 2022 to 19.48 billion yuan in 2023 [8]. Market Trends - The insurance sector, particularly Guohua Life, has been adversely affected by a wave of policy cancellations, with surrender payments reaching 3.036 billion yuan in 2021 and 3.030 billion yuan in 2022, accounting for over 79% of insurance revenue during those years [5]. - The declining interest rate environment has also pressured Guohua Life's profitability, leading to increased reserve requirements [2][6]. Related Parties and Transactions - Tianmao Group has significant receivables from related parties, amounting to 680 million yuan, primarily from Wuhan Guorong Real Estate [10]. - There are allegations of improper use of insurance funds, with reports indicating that these funds have been directed towards real estate projects and other investments [12].
两跌停后刘益谦“火速”回购,天茂集团被证监会立案调查,地产腾挪迷局待解
Hua Xia Shi Bao· 2025-05-08 02:51
| · 中国移动 令 | 下午7:53 | | | --- | --- | --- | | く 気 | 天茂集团-龙虎榜 | [7] Q | | ~ 买八营业部 0 | | 买入/卖出 | | ● 中信证券上海环球金融中心 ... | | 9999万 | | | | 0 | | 华鑫证券上海分公司 | | 2384万 | | 198次 46.46% 量化打板 | | 26.19万 | | 光大证券金华宾虹路证券营 ... | | 1546万 | | 9次 11.11% 落升(江南神鹰) | | 5.41万 | | 广发证券上海龙华路证券营 ... | | 837 7 | | | | O | | 东方财富证券拉萨金融城南 ... | | 817万 | | 774次 28.42% 互联网营业部 | | 520万 | | ~ 卖出营业部 | | 卖出/买入 | | 恒泰证券上海张杨路证券营 ... | | 1398万 | | 1次 100% | | 38.69万 | | 浙商证券金华分公司 | | 1269万 | | | | 86.30万 | | 招商证券北京建国路证券营 ... | | 1161万 | 华夏时报( ...
天茂集团年报“难产”被立案,业绩预告亏损、现金流承压?
2 1 Shi Ji Jing Ji Bao Dao· 2025-05-07 06:04
南方财经全媒体记者 孙诗卉 上海报道 5月6日,天茂集团公告,于2025年5月6日收到中国证券监督管理委员会(以下简称"中国证监会")的《立案告知书》,因涉嫌未按期披露定期报告,根据相 关法律法规,中国证监会决定对公司立案。天茂集团表示,将积极配合中国证监会的相关工作,并严格按照规定及监管要求履行信息披露义务。目前公司经 营情况正常。 天茂集团原定于4月29日发布2024年度报告及2025年一季度报告,然而却在当天发布公告称,因定期报告涉及的部分信息需要进一步补充提供,无法在法定 期限内披露上述定期报告。 目前,天茂集团已经自2025年5月6日起停牌。根据相关要求,若停牌两个月内仍未披露年报,将被实施退市风险警示。退市风 险警示后两个月内仍未披露符合要求的年报,深交所将终止股票上市。 而这并非国华人寿一家面临的问题,相关业内人士对21世纪经济报道记者表示,去年以来,满期兑付高峰的到来,对于中小险企来说都是一个挑战,面对满 期兑付高峰,险企需要加强现金流监控和应急管理,保持充足的现金流以应对客户支付要求。 此外,"报行合一"政策和"一对三"放开的落实,也对国华人寿的保费收入产生了不小的影响,随着银保渠道竞争压力 ...
天茂集团年报“难产”触发退市警报 遭证监会立案调查
Xin Lang Zheng Quan· 2025-05-07 02:57
Core Viewpoint - Tianmao Group's failure to disclose its 2024 annual report and 2025 Q1 report within the legal deadline has led to a suspension of trading by the Shenzhen Stock Exchange and an investigation by the China Securities Regulatory Commission (CSRC), highlighting issues related to corporate governance, financial risk, and regulatory compliance [1][2][3] Group 1: Disclosure Issues - The company was scheduled to disclose its periodic reports on April 29, 2025, but failed to do so by the legal deadline of April 30 due to the need for further verification of certain information [1] - Trading of the company's stock was suspended starting May 6, 2025, and if the annual report is not disclosed within two months, it will face a delisting risk warning (ST) [1][2] - The CSRC has initiated an investigation into the company for failing to disclose regular reports on time, which increases the risk of delisting [1][2] Group 2: Financial Performance - Tianmao Group has been experiencing continuous losses, reporting a loss of 652 million yuan in 2023, with an expected loss of between 500 million to 750 million yuan in 2024, primarily due to the underperformance of its subsidiary, Guohua Life Insurance [1][2] - Guohua Life Insurance has faced challenges such as increased reserve requirements due to declining interest rates, investment losses (e.g., losses from Guanghui Automotive stocks), and a 23.8% year-on-year decline in premium income in Q1 2025 [1][2] Group 3: Market Reaction and Investor Sentiment - The company's stock price has dropped over 40% from its peak at the beginning of the year, closing at 2.74 yuan before the suspension, resulting in a market capitalization reduction to 13.5 billion yuan [2] - The company's measures, such as a share buyback of 36.49 million shares, have not effectively restored market confidence, with investors expressing skepticism about the company's explanations and fearing potential financial fraud or asset issues [2][3] Group 4: Broader Industry Implications - The incident raises concerns about the financial stability of the insurance industry, particularly for small and medium-sized insurance companies under pressure from declining interest rates and reserve requirements [2][3] - The case serves as a warning for the capital market, emphasizing the need for listed companies to strengthen internal controls and audit cooperation to avoid risks stemming from disclosure deficiencies [3]
天茂集团(000627) - 关于收到中国证券监督管理委员会立案告知书的公告
2025-05-06 13:45
证券代码:000627 证券简称:天茂集团 公告编号:2025-015 天茂实业集团股份有限公司 公司指定的信息披露媒体为《中国证券报》《上海证券报》《证券时报》和巨潮资讯网 (http://www.cninfo.com.cn),公司相关信息均以在上述指定信息披露媒体登载的公告为 准。敬请广大投资者关注公司相关公告,理性投资,注意投资风险。 因涉嫌未按期披露定期报告,根据《中华人民共和国证券法》《中华人民共和国行政处 罚法》等法律法规,2025 年 5 月 6 日,我会决定对你立案。 特此告知。" 公司将积极配合中国证监会的相关工作,并严格按照规定及监管要求履行信息披露义务。 目前公司经营情况正常。 关于收到中国证券监督管理委员会立案告知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 天茂实业集团股份有限公司(以下简称"公司")于 2025 年 5 月 6 日收到中国证券监督 管理委员会(以下简称"中国证监会")的《立案告知书》(证监立案字 00502025004 号), 具体内容如下: "天茂实业集团股份有限公司: 特此公告。 天茂实业集团股份有限 ...
天茂集团:因涉嫌未按期披露定期报告 收到中国证监会立案告知书
news flash· 2025-05-06 13:38
天茂集团(000627)公告,公司于2025年5月6日收到中国证监会的《立案告知书》。因涉嫌未按期披露 定期报告,证监会决定对公司立案。公司将积极配合相关工作,并履行信息披露义务。目前公司经营情 况正常。 ...
财达证券晨会纪要-20250506
Caida Securities· 2025-05-06 12:31
Summary of Key Points Core Insights - The report highlights various companies undergoing temporary suspensions of trading due to different reasons, including financial disclosures and potential delisting risks. This indicates a volatile market environment where investor confidence may be affected by such events [2][3][4]. Company Specifics - ST Jiuzhi (000989) announced a temporary suspension of trading on May 6, 2025, due to the cancellation of other risk warnings [2]. - In the case of ST Gongzhi (000584), trading was suspended due to a risk warning regarding potential delisting, effective from April 28, 2025 [2]. - ST Hengli (000622) and Tianmao Group (000627) also faced trading suspensions due to their inability to disclose periodic reports within the legal timeframe, effective from May 6, 2025 [2]. - Binhai Energy (000695) is undergoing a trading suspension as it plans to issue shares for asset acquisition and raise matching funds, effective from April 30, 2025 [2]. - Electric Power Investment Energy (002128) is also suspended for similar reasons related to asset acquisition and related party transactions, effective from May 6, 2025 [2]. Industry Context - The report reflects a broader trend in the market where companies are facing increased scrutiny and regulatory challenges, leading to trading suspensions. This could signal potential investment risks in the affected sectors [2][3][4].
8家A股上市公司年报至今仍“难产” 这家公司停牌前为何股价还在涨?
Mei Ri Jing Ji Xin Wen· 2025-05-06 11:34
Core Viewpoint - Eight A-share listed companies have failed to disclose their annual reports on time, with some actively pursuing delisting, while others face verification issues [1][2][3]. Group 1: Companies with Delayed Annual Reports - The eight companies include Yulong Co., AVIC Industry Finance, Puli Tui, ST Xinchao, Zitian Technology, Jinlitai, Tianmao Group, and *ST Hengli [2][3]. - Among these, Yulong Co., ST Xinchao, AVIC Industry Finance, and Tianmao Group have market capitalizations exceeding 10 billion yuan, with AVIC Industry Finance reaching 30.6 billion yuan [2]. - The remaining four companies have significantly lower valuations, with Jinlitai around 2 billion yuan and the others below 2 billion yuan [2]. Group 2: Reasons for Delayed Reports - Yulong Co. and AVIC Industry Finance are actively pursuing delisting, which prevents them from timely disclosing their 2024 annual reports [3]. - Puli Tui has received a decision from the Shenzhen Stock Exchange regarding the termination of its stock and convertible bonds [3]. - Jinlitai's delay is due to incomplete verification of financial information, while Tianmao Group and ST Xinchao require further information verification [3]. - *ST Hengli cited the need for additional information and delays from the auditing firm as reasons for its report delay [3]. - Zitian Technology failed to complete its audit due to not hiring an annual audit accountant [3]. Group 3: Stock Performance Amid Report Delays - Despite the report delays, ST Xinchao's stock price increased by 38.36% in April, possibly due to competitive takeover offers [4][5]. - In contrast, Tianmao Group and *ST Hengli experienced stock price declines after announcing their report delays, with Tianmao Group's stock hitting the limit down for two consecutive days [4][5]. - The overall market reaction indicates a divergence in investor sentiment, with some companies facing significant operational risks due to their inability to disclose reports on time [5].
今日看点|北交所为试点股票启用新证券代码





Jing Ji Guan Cha Bao· 2025-05-06 01:06
经济观察网讯 5月6日重点关注的财经要闻与资本市场大事: (原标题:今日看点|北交所为试点股票启用新证券代码) 5月6日,21家公司共发布21个股票回购相关进展。其中,2家公司首次披露股票回购预案,14家公司披 露股票回购实施进展,5家公司回购方案已实施完毕。 从首次披露回购预案来看,当日共1家公司股票回购预案金额超千万。科思科技、毅昌科技回购预案金 额最高,分别拟回购不超5000.0万元、66.36万元。从回购实施进展来看,美的集团、长春高新、九安医 疗回购金额最高,分别回购5.54亿元、4.0亿元、3.7亿元。从已完成回购来看,当日共4家公司回购金额 超千万。华工科技、天茂集团、万邦德已完成回购金额最高,分别回购3.95亿元、9998.26万元、 5998.85万元。 4、美国3月贸易帐、欧元区3月PPI月率等数据将公布。 (数据来源Wind,内容不构成任何投资建议) 1、北交所为试点股票启用新证券代码 近日,北交所发布通知,北交所存量上市公司代码切换试点工作总体准备就绪,拟于2025年5月6日正式 上线。根据通知,2025年5月1日至2025年5月5日期间,北交所组织开展代码切换与通关测试,自2025年 ...